Background {#s0001}
==========

In Denmark, general practitioners (GPs) are responsible for more than 80% of all drug prescriptions,\[[@C1]\] and they have responsibility for their listed patients 24/7 all year round.\[[@C4]\] Insight into prescription patterns in health-care services is crucial to ensure the best possible utilisation of resources and to reduce the risk of medical errors.\[[@C5]\] Former studies have described the prescription patterns among GPs in daytime,\[[@C1],[@C6]\] but little is known about the extent and types of drugs prescribed in the out-of-hours (OOH) primary care services. Insight into prescription patterns in OOH care may provide a basis for monitoring, evaluating and improving the prescription behaviour.

Danish GPs have collaborated in large-scale OOH cooperatives since 1992. These provide patient care from 4 pm to 8 am on weekdays, all weekends and public holidays. OOH primary care is freely accessible for patients, and all contacts are triaged by a GP by telephone. Thus, all patient calls are managed by GPs as either telephone consultations or further referral to a subsequent clinic consultation or home visit.\[[@C9]\] OOH GPs are paid a fee-for-service. The fee for a telephone consultation is higher than the fee for a telephone referral to a subsequent face-to-face contact to reflect the differences in time consumption and also to encourage the triaging GP to use telephone advice whenever possible.\[[@C6]\]

As OOH care involves large numbers of contacts, the accumulated effects of prescription patterns may have extensive socioeconomic and health-related consequences.

The aim of this study was to examine the current practice for drug prescribing in Danish OOH primary care with respect to patient age and gender, contact types and types of drugs prescribed.

Materials and methods {#s0002}
=====================

Design and setting {#s0003}
------------------

This population-based retrospective observational study on prescriptions in Danish OOH primary care included all contacts to the OOH primary care service in the Central Denmark Region (1.2 mill inhabitants) during one year from 1 June 2010 to 31 May 2011.

Data {#s0004}
----

All data were collected from the OOH electronic medical record system. Drug prescriptions are processed through an electronic prescription function.

Data included information on the contact: date and time of contact, patient age and gender, contact type (i.e. telephone consultation, clinic consultation or home visit) and all prescriptions coded according to the global Anatomical Therapeutic Chemical (ATC) Classification system.\[[@C12]\]

Patient age was categorised into seven age groups (0--4, 5--13, 14--17, 18--40, 41--60, 61--75 and \>75 years). Prescriptions were categorised according to 1st, 2nd and 3rd levels of ATC coding system.\[[@C12]\]

Analysis {#s0005}
--------

The frequencies and proportions of contacts with at least one prescription were calculated for each type of contact. The rate of contacts resulting in prescriptions (PC rate) was defined as the number of contacts with one or more prescriptions per 100 contacts. PC rate was calculated with 95% confidence intervals (95% CI) for age and gender stratified for all contacts and for contact type. For specific drugs, we calculated a prescription rate (Pr. rate) defined as the number of prescriptions of a specific drug per 100 contacts. The Pr. rate was calculated with 95% CI for the 10 most frequently prescribed drugs. These drugs were presented for 1st, 2nd and 3rd levels of ATC coding stratified for contact type. Groups of medication accounting for less than 1% of prescriptions were categorised into "rest" for all types of contacts. Analyses were performed in STATA version 12.

Results {#s0006}
=======

Rate of contacts resulting in prescriptions {#s0007}
-------------------------------------------

In total, 644,777 contacts were made to the OOH. Of these, 154,668 (24.0%) contacts involved at least one prescription ([Table 1](#TB1){ref-type="table"}). The PC rate varied with contact type: 32.9 (95% CI: 32.6--33.1) for clinic consultations, 21.9 (95% CI: 21.8--22.0) for telephone consultations, and 14.3 (95% CI: 14.0--14.5) for home visits ([Table 2](#TB2){ref-type="table"}). Female patients more often received a prescription than male patients (PC rates: 25.1 (95% CI: 25.0--25.3) vs. 22.6 (95% CI: 22.5--22.8)). The gender-related difference was most profound for telephone consultations. The difference found for telephone consultations was partly due to prescriptions of "sex hormones and modulators of the genital system" (GO3) and "sulphonamides and trimethoprim" (J01E) as these two types accounted for 10.2% of all prescriptions made by telephone for women (data not shown).

###### 

Distribution of contacts with and without prescription(s) per contact type.

                            All contacts      Contacts with at least one prescription   Contacts without prescription
  ------------------------- ----------------- ----------------------------------------- -------------------------------
  Telephone consultations   382,748 (59.4)    83,785 (21.9)                             298,963 (78.1)
  Clinic consultations      180,032 (27.9)    59,167 (32.9)                             120,865 (67.1)
  Home visits               81,997 (12.7)     11,716 (14.3)                             70,281 (85.7)
  Total                     644,777 (100.0)   154,668 (24.0)                            490,109 (76.0)

###### 

Number of contacts with at least one prescription per 100 OOH contacts (PC rate) according to age, gender and contact type.

                 *N*       All contacts PC rate(95% CI)   Telephone consultations PC rate (95% CI)   Clinic consultations PC rate (95% CI)   Home visits PC rate(95% CI)
  -------------- --------- ------------------------------ ------------------------------------------ --------------------------------------- -----------------------------
  Male           65,817    22.6 (22.5--22.8)              19.3 (19.1--19.5)                          32.6 (32.3--32.9)                       14.5 (14.2--14.9)
  Female         88,851    25.1 (25.0--25.3)              23.9 (23.7--24.1)                          33.1 (32.8--33.4)                       14.1 (13.7--14.4)
  0--4 years     26,581    21.1 (20.9--21.3)              17.2 (17.0--17.5)                          29.4 (28.9--29.8)                       14.0 (13.0--15.0)
  5--13 years    13,212    20.9 (20.6--21.2)              15.6 (15.2--16.0)                          29.5 (28.9--30.1)                       13.7 (12.4--15.1)
  14--17 years   5728      21.6 (21.1--22.1)              18.5 (17.9--19.1)                          27.9 (27.0--28.8)                       12.2 (10.7--13.9)
  18--40 years   53,996    27.6 (27.4--27.8)              25.9 (25.6--26.1)                          34.8 (34.4--35.2)                       12.3 (11.7--12.8)
  41--60 years   31,846    27.7 (27.4--27.9)              26.7 (26.4--27.0)                          37.5 (36.9--40.0)                       12.9 (12.4--13.4)
  61--75 years   13,304    21.9 (21.6--22.2)              20.1 (19.6--20.5)                          35.3 (34.5--36.2)                       13.3 (12.8--13.8)
  \>75 years     10,001    17.4 (17.1--17.7)              17.8 (17.4--18.3)                          29.5 (27.9--31.1)                       15.5 (15.1--16.0)
  Total          154,668   24.0 (23.9--24.1)              21.9 (21.8--22.0)                          32.9 (32.6--33.1)                       14.3 (14.0--14.5)

PC rate: number of contacts with at least one prescription per 100 contacts.

*p* for rate between gender for all contacts and telephone consultations \<0.01 and for clinic consultations and home visit \<0.05.

A higher PC rate was found for patients aged 18--40 years compared to all other age groups ([Table 2](#TB2){ref-type="table"}). This pattern differed for home visits, for which a higher PC rate was found for children younger than four years and for patients older than 75 years.

[Table 3](#TB3){ref-type="table"} presents all prescriptions in the study period according to 1st, 2nd and 3rd levels of the ATC coding system. In total, 167,883 drugs were prescribed; 53.4% of these were prescribed by telephone. For almost all drug types most prescriptions were made in telephone consultations, except for "anti-infectives for systemic use" (J) and "systemic hormonal preparations" (H) ([Table 3](#TB3){ref-type="table"}).

###### 

All prescriptions in the 1-year study period presented with 1st, 2nd and 3rd ATC code level per contact type.

  ATC code level          Telephone consultations   Clinic consultations                                                    Home visits     All                            
  ---------------- ------ ------------------------- ----------------------------------------------------------------------- --------------- --------------- -------------- ---------------
  J                                                 Anti-infectives for systemic use                                        26,679 (29.7)   41,042 (63.1)   8676 (65.6)    76,397 (45.5)
                   J01                              Antibacterials                                                          24,286          40,261          8,556          73,103
                          *J01C*                    *Beta-lactam antibacterials, penicillins*                               *18,218*        *35,330*        *7113*         *60,661*
                          *J01F*                    *Macrolides and lincosamides*                                           *1634*          *3657*          *1018*         *6309*
                          *J01E*                    *Sulfonamides and trimethoprim*                                         *3577*          *632*           *132*          *4341*
                          *J01M*                    *Quinolone antibacterials*                                              *631*           *458*           *273*          *1362*
                          *Rest*                    *J01A, J01D, J01G, J01X*                                                *226*           *184*           *20*           *430*
                   J05    *J05A*                    Antivirals (*direct acting*)                                            1005            607             87             1699
                   J02    *J02A*                    Antimycotics (s*ystemic use*)                                           1369            172             31             1572
                   Rest                             J06, J07                                                                19              2               2              23
  S                                                 Sensory organs                                                          16,058 (17.9)   5722 (8.8)      360 (2.7)      22,140 (13.2)
                   S01                              Ophtalmologicals                                                        15,071          3982            286            19,339
                          *S01A*                    *Anti-infectives*                                                       *13,937*        *3470*          *249*          *17,656*
                          *Rest*                    *S01B, S01C, S01E, S01F, S01G, S01H, S01X*                              *1134*          *512*           *37*           *1683*
                   S02                              Otologicals                                                             807             1165            42             2014
                          *S02C*                    *Corticosteroides/anti-infectives comb*                                 *367*           *838*           *32*           *1237*
                          *S02A*                    *Anti-infectives*                                                       *440*           *327*           *10*           *777*
                   Rest                             S03                                                                     180             575             32             787
  *N*                                               Nervous system                                                          11,247 (12.6)   2457 (3.8)      1120 (8.5)     14,824 (8.8)
                   N02                              Analgetics                                                              6148            2058            829            9035
                          *N02A*                    *Opioids*                                                               *4428*          *1462*          *709*          *6599*
                          *N02C*                    *Antimigraine preparations*                                             *1174*          *66*            *21*           *1261*
                          *Rest*                    *N02B*                                                                  *546*           *530*           *99*           *1175*
                   N06                              Psychoanaleptics                                                        2460            75              33             2568
                          *N06A*                    *Antidepressant*                                                        *2214*          *49*            *29*           *2292*
                          *Rest*                    *N06B, N06D*                                                            *246*           *26*            *4*            *276*
                   N05                              Psycholeptics                                                           1381            224             214            1819
                          *N05B*                    *Antiepileptics*                                                        *511*           *145*           *142*          *798*
                          *Rest*                    *N05A, N05C*                                                            *870*           *79*            *72*           *1021*
                   N03    N03A                      Antiepileptics                                                          924             33              13             970
                   Rest                             N01, N04, N07                                                           334             67              64             432
  R                                                 Respiratory system                                                      8850 (9.9)      4947 (7.6)      624 (4.7)      14,421 (8.6)
                   R03                              Drugs for obstructive airway diseases                                   4339            2493            418            7250
                          *R03A*                    *Adrenergics, inhalants*                                                *3005*          *1663*          *320*          *4988*
                          *R03B*                    *Other inhalants*                                                       *1007*          *503*           *60*           *1570*
                          *Rest*                    *R03C, R03D (for systemic use)*                                         *327*           *327*           *38*           *692*
                   R06    R06A                      Antihistamines for systemic use                                         2512            1199            74             3785
                   R05                              Cough and cold preparations                                             1162            816             113            2091
                   Rest                             R01, R02 (Nasal/throat preparations)                                    837             439             19             1295
  M                                                 Musculo-skeletal system                                                 6323 (7.1)      4129 (6.3)      564 (4.3)      11,016 (6.6)
                   M01    M01A                      NSAIDs                                                                  6192            4044            555            10,791
                   Rest                             M02, M03, M04, M05                                                      131             85              9              225
  A                                                 Alimentary tract and metabolism                                         5864 (6.5)      2230 (3.4)      852 (6.4)      8946 (5.3)
                   A02                              Acid-related disorders                                                  1246            1070            316            2632
                   A03                              Functional gastrointestinal disorders[^a^](#TF3){ref-type="table-fn"}   1409            492             289            2190
                   A10                              Drugs used in diabetes                                                  1073            9               7              1089
                   Rest                             A01, A04, A06-09, A11, A12                                              2136            659             240            3035
  D                                                 Dermatologicals                                                         3587 (4.0)      2823 (4.3)      158 (1.2)      6568 (3.9)
                   D06                              Antibiotics/chemotherapeutics[^b^](#TF4){ref-type="table-fn"}           1561            1334            56             2951
                   D07                              Topical dermatological corticosteroids                                  1109            1010            65             2184
                   Rest                             D01, D02, D04, D05, D08, D10, D11                                       917             479             37             1433
  P                                                 Antiparasitic products                                                  3872 (4.3)      353 (0.5)       29 (0.2)       4254 (2.5)
                   P02    P02C                      Antinematodal agents                                                    3566            47              4              3617
                   Rest                             P01, P03                                                                306             306             25             637
  C                                                 Cardiovascular system                                                   3037 (3.4)      628 (1.0)       212 (1.6)      3877 (2.3)
                   C05    C05A                      Haemorrhoids and anal fissures                                          1162            331             38             1531
                   Rest                             C01, C02, C03, C05B-C, C07, C08, C09, C10                               1875            297             174            2246
  G                                                 Genito-urinary system/sex hormones                                      2801 (3.1)      89 (0.1)        10 (0.1)       2900 (1.7)
                   G03    G03A                      Hormonal contraceptives systemic                                        1949            13              3              1965
                   Rest                             G01, G02, G03B-H, G04                                                   852             76              7              935
  H                                                 Systemic hormonal preparations                                          674 (0.8)       580 (0.9)       585 (4.4)      1839 (1.1)
                   H02    H02A                      Corticosteroids (for systemic use)                                      403             574             583            1.560
                   Rest                             H01, H03, H04, H05                                                      271             6               2              259
  Rest                                              B, L, V[^c^](#TF5){ref-type="table-fn"}                                 605 (0.7)       70 (0.1)        26 (0.2)       701 (0.4)
  All                                                                                                                       89,597 (100)    65,070 (100)    13,216 (100)   167,883 (100)

Propulsives (*A03F*) account for 93.4%.

Antibiotics for topical use (*D06A*) account for 87.4%.

Blood and blood-forming organs; L: antineoplastic and immunomodulating agents; V: various.

"Beta-lactam antibacterial, penicillin" (J01C) accounted for 36.1% of all prescriptions and was the most frequently prescribed type of drug, in particular in clinic consultations ([Table 4](#TB4){ref-type="table"}). The 10 most frequently prescribed drugs accounted for 66.5% of all telephone prescriptions, 82.8% at clinic consultations and 86.3% at home visits.

###### 

The 10 most frequently prescribed drug types (ATC-code, 3rd level). Proportion (%) of all prescriptions and prescription rate (Pr. rate)[^a^](#TF6){ref-type="table-fn"} for all contacts and per contact type.

  All contacts                               \%     Pr. rate (95% CI)   Telephone consultations                           \%     Pr. rate (95% CI)
  ------------------------------------------ ------ ------------------- ------------------------------------------------- ------ -------------------
  Penicillin (J01C)                          36.1   9.4 (9.3--9.5)      Penicillin (J01C)                                 20.3   4.8 (4.7--4.8)
  Ophtalmological anti-infectives (S01A)     10.5   2.7 (2.7--2.8)      Ophtalmological anti-infectives (S01A)            15.6   3.6 (3.6--3.7)
  NSAIDs (M01A)                              6.4    1.7 (1.6--1.7)      NSAIDs (M01A)                                     6.9    1.6 (1.6--1.7)
  Opioids (N02A)                             3.9    1.0 (1.0--1.0)      Opioids (N02A)                                    4.9    1.2 (1.1--1.2)
  Macrolides and lincosamides (J01F)         3.8    1.0 (1.0--1.0)      Sulfonamides and trimethroprim (J01E)             4.0    0.9 (0.9--1.0)
  Adrenergics, inhalants (R03A)              3.0    0.8 (0.8--0.8)      Antinematodal agents (P02C)                       4.0    0.9 (0.9--1.0)
  Sulfonamides and trimethroprim (J01E)      2.6    0.7 (0.7--0.7)      Adrenergics, inhalants (R03A)                     3.4    0.8 (0.8--0.8)
  Antihistamines (for systemic use) (R06A)   2.3    0.6 (0.6--0.6)      Antihistamines for systemic use (R06A)            2.8    0.7 (0.6--0.7)
  Antinematodal agents (P02C)                2.2    0.6 (0.5--0.6)      Antideppresants (N06A)                            2.5    0.6 (0.6--0.6)
  Antibiotics for topical use (D06A)         1.5    0.4 (0.4--0.4)      Hormonal contraceptives for systemic use (G03A)   2.2    0.5 (0.5--0.5)
  Clinic consultations                                                  Home visits                                              
  Penicillin (J01C)                          54.3   19.6 (19.4--19.8)   Penicillin (J01C)                                 53.8   8.7 (8.5--8.9)
  NSAIDs (M01A)                              6.2    2.2 (2.2--2.3)      Macrolides and lincosamides (J01F)                7.7    1.2 (1.2--1.3)
  Macrolides and lincosamides (J01F)         5.6    2.0 (2.0--2.1)      Opioids (N02A)                                    5.4    0.9 (0.8--0.9)
  Ophtalmological anti-infectives(S01A)      5.3    1.9 (1.9--2.0)      Corticosteriods for systemic use (H02A)           4.4    0.7 (0.7--0.8)
  Adrenergic inhalants (R03A)                2.6    0.9 (0.9--1.0)      NSAIDs (M01A)                                     4.2    0.7 (0.6--0.7)
  Opioids (N02A)                             2.2    0.8 (0.8--0.9)      Adrenergics, inhalants (R03A)                     2.4    0.4 (0.3--0.4)
  Antihistamines for systemic use (R06A)     1.8    0.7 (0.6--0.7)      Drugs for peptic ulcers and GERD (A02B)           2.3    0.4 (0.3--0.4)
  Antibiotics for topical use (D06A)         1.8    0.7 (0.6--0.7)      Propulsives (A03F)                                2.1    0.3 (0.3--0.4)
  Otologicals (S02A + S02C)                  1.8    0.6 (0.6--0.7)      Quinolone antibacterials (J01M)                   2.2    0.3 (0.3--0.3)
  Drugs for peptic ulcers (A02B)             1.6    0.5 (0.5--0.6)      Ophtalmological anti-infectives (S01A)            1.9    0.3 (0.3--0.3)

Number of prescriptions of a specific drug type per 100 contacts.

Discussion {#s0008}
==========

Main findings {#s0009}
-------------

About 25% of all contacts to OOH primary care involved prescription of one or more drugs. The highest rate of contacts resulting in prescriptions was found for clinic consultations (nearly one-third). Overall, adults aged 18--60 years received prescription(s) more often than other age groups. Yet, for home visits, the highest PC rate was found for patients aged more than 75 years. More than half of all prescriptions were made in telephone consultations, and these encompassed a larger variation of drugs than prescriptions made in face-to-face consultations. Thus, for almost all types of drugs, telephone prescriptions accounted for the majority of prescriptions made. "Anti-infective drugs" (for systemic and local use) were by far the most frequently prescribed type of drugs and accounted for about 60% of all prescriptions made by the OOH service.\[[@C13]\] Other frequently prescribed types of drugs were "NSAIDs", "opioids", "adrenergic inhalants" and "antihistamines".

Discussion of results {#s0010}
---------------------

The rate of contacts to the OOH primary care is rather high in Denmark compared to other European countries.\[[@C14]\] The consumption in the Central Region is comparable with the rest of the country.

Few studies have mapped the prescribing patterns in primary care,\[[@C1],[@C6]\] and only one study have addressed prescriptions in OOH primary care.\[[@C15]\]

As a large number of OOH contacts involve drug prescription, the economic and clinical aspects of the prescribing patterns in OOH care are significant. In daytime primary care, the frequency of prescribing is even higher (from one third to half of all consultations).\[[@C1]\]

The finding of more frequent prescriptions for female patients correlates with day time conditions.\[[@C1]\] Children and older patients (\>75 years) were less likely to receive a prescription by telephone than other age groups. This may be related to a higher need for making a clinical examination in these age groups in order to determine the severity of the presented health problem and the relevant treatment option.

The high proportion of prescriptions made by telephone could indicate an overconsumption of OOH in regard to treatment of non-urgent health problems and prescription based on questionable clinical indications.\[[@C7]\] On the other hand, the considerable number of telephone consultations could also indicate a cost-effective OOH system that manages to meet and handle most health needs at low cost. Furthermore, the considerable proportion of telephone prescriptions may also be related to the organisation of OOH care with GPs as the triage professionals.

The PC rate found for home visits with prescription(s) in about one of seven contacts was lower than expected. This may be related to a higher frequency of hospital referrals and patients already being in possession of relevant medication or dispense of medicine from the home visiting GP's bag.

The typical indications for the most frequently prescribed types of drugs in this study ("anti-infectives", "NSAIDs", "opioids", "adrenergics", "inhalants" and "antihistamines") seem to be consistent with the aim of OOH primary care to manage common urgent health requests. The diagnostic patterns on reasons for encounter with OOH primary care also confirm this association as infectious diseases and pain-related symptoms seem to be prevailing.\[[@C5],[@C16]\] However, the diversity of drugs was larger among drugs prescribed by telephone than among drugs prescribed in face-to-face contacts. "Contraceptives" and "antidepressants" were among the 10 most frequently prescribed drugs by telephone, which may indicate that some prescriptions were related to renewal of prescriptions or lost, missing or mislaid medications. In an earlier study, we found that prescription renewal was the primary reason for encounter in 5% of all OOH telephone consultations.\[[@C16]\]

Patients should contact the OOH service only in case of a health problem that cannot wait until normal office hours. In this perspective, the 32.9% of clinic consultations resulting in at least one prescription may not be that high.

In the present study clinical information such as reason for encounter was not collected but earlier studies showed that patients in OOH often present with health issues related to infection.\[[@C15],[@C16]\] Consequently, the antibiotic prescription rate will be high, in particular when dealing with acute health problems like in the OOH. Also many patients contacting OOH service may expect to have a condition requiring treatment with medication, and most GPs are aware of these assumptions.\[[@C17]\] A study from Australia showed that patients who expected to receive medication were nearly three times more likely to get a prescription and that the highest frequency of prescriptions were found in cases where the doctors assessed patients to expect discharge of medication.\[[@C6]\] Such mechanisms may lay behind some of the findings of this study, for example that anti-infective eye drops accounted for 10.5% of all prescriptions.

The "pressure for treatment" may for some part be divided into the "demand for treatment", which originate from the patients and their relatives, and doctor's "urge for delivering treatment/a solution". These two focal points should be kept in mind if we intend to reduce the number of inappropriate prescriptions and bridge the perceptual gap between patient and doctor in the clinical encounter. However, doctors should also be aware that a number of other factors also impact their decisions on prescriptions, such as financial pressure.\[[@C17]\]

Strengths and limitations {#s0011}
-------------------------

This study included all drug prescriptions made during a complete year in the Danish OOH primary care service. The large sample size ensured high statistical precision with the possibility to make inference at third ATC level. The data were collected retrospectively, meaning that the GPs had no knowledge of an ongoing study of OOH prescriptions, and their performance was consequently not altered. As all prescriptions were completed electronically, the data hold high validity and completeness.\[[@C2]\] However, the GPs also had the option to make a handwritten prescription on paper, but as the GPs on home visits had a laptop with online possibility of prescribing this happened rarely to our knowledge. Still, the paper option might have led to an underestimation of drug prescriptions during home visits. The data did not allow us to link prescriptions with indications. Thus, we cannot discuss the appropriateness of prescriptions, which could be particular interesting for telephone consultations.

Conclusion {#s0012}
==========

Drug prescriptions are made in 33% of all clinic consultations, 22% of all telephone consultations and 14% of all home visits in OOH primary care. More than half of all drugs were prescribed by telephone. The most frequently prescribed type of drug was "anti-infective drugs", followed by "NSAIDs", "opioids", "adrenergic inhalants" and "antihistamines".

Clinical implications and future recommendations {#s0013}
------------------------------------------------

Appropriate prescribing is a complex topic. Decisions strongly depend on a wide range of aspects related to both the patient and the prescribing doctor, for example the clinical situation, the working conditions, public health policies and personal and socio-economic factors.\[[@C1],[@C6],[@C18],[@C19]\] Such aspects need to be further addressed in order to assess the appropriateness of the current prescribing behaviours in OOH primary care.

Our findings extend the ongoing discussion regarding the safety and feasibility of drug prescribing at telephone consultations. Our figures underpin the relevance of studying the most frequent types of drug prescriptions based on telephone consultations in OOH primary care and to discuss the appropriateness of these prescriptions.
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